United States

People: Neurocrine Biosciences Inc (NBIX.O)

NBIX.O on Nasdaq

26 Sep 2017
Change (% chg)

$-1.45 (-2.46%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Mollica, Joseph 

Dr. Joseph A. Mollica, Ph.D., serves as an Independent Director of Neurocrine Biosciences Inc. He has served on the Board of Directors since June 1997 and as Chairman of the Board from 1998 until 2011. From 2004 to 2008, Dr. Mollica served as the Chairman of the Board of Pharmacopeia Drug Discovery, Inc., a biopharmaceutical company focused on drug discovery and development. From 1994 to 2004, Dr. Mollica served as the Chairman of the Board of Directors, President and Chief Executive Officer of Accelrys, Inc., the former parent of Pharmacopeia Drug Discovery. From 1987 to December 1993, Dr. Mollica served as Vice President, Medical Products of DuPont Company and then as President and CEO of DuPont Merck Pharmaceutical Company from 1991 to 1993. At Ciba-Geigy Ltd., where he was employed from 1966 to 1986, he served in a variety of positions of increasing responsibility, rising to Senior Vice President of Ciba-Geigy’s Pharmaceutical Division. Dr. Mollica was previously a director of Cytogen Corporation, Celator Pharmaceuticals, Inc., Redpoint Bio Corporation and Genencor International. Over the past 20 years, Dr. Mollica has served on the boards of more than a dozen public, private and not-for-profit boards. He received his B.S. from the University of Rhode Island, his M.S. and Ph.D. from the University of Wisconsin and his Sc.D.h.c. from the University of Rhode Island.

Basic Compensation

Total Annual Compensation, USD 67,000
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 401,700
Fiscal Year Total, USD 468,700

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --